Olof Johnell (Former)
91 – 100 of 164
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2003
-
Mark
The components of excess mortality after hip fracture
(
- Contribution to journal › Article
-
Mark
Cost effectiveness of alendronate (fosamax) for the treatment of osteoporosis and prevention of fractures.
(
- Contribution to journal › Article
-
Mark
Incidence of hospitalized osteoporotic fractures in cohorts with high dietary intake of persistent organochlorine compounds.
(
- Contribution to journal › Article
-
Mark
Effect of raloxifene on the risk of new vertebral fracture in postmenopausal women with osteopenia or osteoporosis: a reanalysis of the Multiple Outcomes of Raloxifene Evaluation trial
(
- Contribution to journal › Article
-
Mark
The burden of musculoskeletal conditions at the start of the new millennium
(
- Contribution to journal › Article
-
Mark
Bone loss and bone size after menopause.
(
- Contribution to journal › Article
-
Mark
Bone loss and bone size after menopause - Reply
(
- Contribution to journal › Letter
- 2002
-
Mark
Bone mineral density in patients with chronic obstructive pulmonary disease treated with budesonide Turbuhaler.
(
- Contribution to journal › Article
-
Mark
Non-participants differ from participants as regards risk factors for vertebral deformities: a source of misinterpretation in the European Vertebral Osteoporosis Study.
(
- Contribution to journal › Article
-
Mark
The epidemiology of total hip replacement in the Netherlands and Sweden - Present status and future needs
(
- Contribution to journal › Article